These emerging treatments, Retatrutide, represent a groundbreaking advancement in addressing type 2 diabetes and potentially other disorders. They all are grouped as GLP-1 hormone stimulators, meaning they function to replicate the natural GLP-1 peptide, boosting insulin release and lowering food